Skip to content

Growing up milk with new fat composition and probiotics to target infections in Indonesian toddlers.

The effects of a growing-up milk containing an optimised fat blend and probiotics on symptoms of gastrointestinal and respiratory infections in Indonesian children between 1 and 3 years of age.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON22249
Enrollment
300
Registered
2012-07-05
Start date
2012-06-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory tract infections, gastrointestinal tract infections

Interventions

Group 1: Standard Growing up milk
Group 2: Growing up milk + new fat blend
Group 3: Growing up milk + new fat blend + probiotic 1
Group 4: Growing up milk + new fat blend + probiotic 2.

Sponsors

FrieslandCampina Innovation Infant & Toddler Nutrition
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Healthy Indonesian children; 2. Between 1 and <3 years of age; 3. Non-breastfed.

Exclusion criteria

Exclusion criteria: 1. In sick condition 1 month before the start of the study; 2. Receiving antibiotics treatment 2 weeks before the study starts; 3. Breastfeeding 2 months prior to the start of the intervention period; 4. Consumption of pre-, pro- or synbiotic products at least 2 weeks prior to the intervention; 5. Symptoms of chronic/congenital diseases and disabilities, suspected Tuberculosis by clinical examination, and/or history of allergic diseases; 6. Use of medication that can interfere with the study 2 months before the start, such as strong anti-inflammatory drugs; 7. History of lactose intolerance; 8. History of cow’s milk allergy; 9. Siblings of already included children that are living in the same household, except if it is a twin sibling; 10. Participation in another clinical trial at the same time or 2 months prior to the study.

Design outcomes

Primary

MeasureTime frame
Duration of respiratory tract and gastrointestinal tract infection episode.

Secondary

MeasureTime frame
1. Incidence of infection; 2. Severity of infection; 3. Physical growth; 4. Rotavirus prevalence; 5. Gut microflora; 6. Mucosal inflammation.

Contacts

Public ContactMarjolijn C.E. Bragt - van Wijngaarden

FrieslandCampina Innovation Infant & Toddler Nutrition P.O. Box 226

marjolijn.bragt@frieslandcampina.com+31 (0)58 2992447

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)